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Number of patients 23
Number of lesions treated 43
Number of stents 45
Stent diameter (mm) 2.90.6
Stent length (mm) 17.16.2
Length of follow-up (days) 709348
MI/mortality on follow-up 0
Binary restenosis 5.57% (3/45)
Target vessel revascularization 16.7% (5/30)
Target lesion revascularization 6.98% (3/43)
Quantitative coronary angiography (QCA)
Pre-
procedure
Post-
procedure
Follow-up p-value
RVD (mm) 2.660.79 2.890.75 2.820.71 <0.05
Diameter stenosis (%) 74.915.9 8.083.63 11.16.67 <0.0001
MLD (mm) 0.650.34 2.650.67 2.490.63 <0.0001
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comSS point). The clinical SS was superior to baseline SS in predicting 3-year POCE
(AUC: 0.595 vs. 0.649, p¼0.008). In subgroup analysis, baseline SS was a predictor
for POCE only in multi-vessel diseases (HR 1.027, 95% CI 1.001-1.054, p¼0.042
per SS point).
Conclusions: CR is an independent predictor of 3-year POCE in patients receiving
PCI. However, even after CR is achieved to make the post-PCI SS zero, baseline SS
still has predictive value of 3-year clinical outcomes. Moreover, the predictivity is was
superior in multi-vessel diseases.
TCT-99
Clinical outcome, safety, patient satisfaction and costs savings of same-day
discharge for elective percutaneous coronary intervention
Beatriz Samaniego1, Jose Miguel Vegas1, Iñigo Lozano1, Juan Rondan Murillo1,
Hernandez Ernesto1, Victor Leon1
1Hospital de Cabueñes, Gijon, Spain
Background: Overnight admission after elective percutaneous coronary inter-
vention(PCI)still constitutes the standard approach in most interventional cardiology
centers. Advances in PCI techniques have reduced the incidence of post-procedure
complications. The objective of this prospective,single-center study was to assess
the feasibility, safety, acceptance and cost savings of same-day discharge PCI
program.
Methods: Eligibility for outpatient management was assessed in 95 consecutive
patients undergoing elective PCI from January 2013 to April 2014. Exclusion
criteria for early discharge were age>80, severe renal failure, LVEF< 35%,
distance from home to hospital >40 km, high risk coronary anatomy or com-
plications during procedure. Major adverse cardiac events,vascular complications
and readmission were assessed 1-day and 1-month post discharge. Troponin,
EKG and a satisfaction survey were collected within 24 hours post PCI sched-
uled visit.
Results: 39 patients (41%) were cleared for discharge. The remaining 56(59%)
stayed overnight for high risk coronary anatomy (n¼51, 91%), chest discomfort
(n¼4, 7%) or treatment with abciximab (n¼1, 2%). Mean post PCI hospital stay
was 8:48 h for outpatients group. None patient was readmitted. There were no
vascular complications. EKG collected in 24-hours-visit show non-speciﬁc changes
in 3 patients. 7 patients hd troponin elevation without angina or EKG ischemic
changes. After one-month follow up only 2 patients had adverse events: a bare
metal stent thrombosis (day 7 after procedure) and 1 gastrointestinal bleeding with
diagnosis of colonic cancer. These complications could not have been avoided with
overnight hospital admission. Early discharge was well valuated with mean patient
satisfaction score of 4,50,5 (1 to 5). 87% of outpatients would choose early
discharge in case of new PCI. Using diagnosis-related groups costs established
in our institution, there were lower cost in the early discharge group, with a mean
cost of 2.480 vs 2.880 Euro in the routine care group. Mean of expense savings
was 16%.
Conclusions: In our experience same-day discharge after elective PCI is feasible, safe
and well accepted in selected patients and results in a cost-saving strategy.
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Background: Transplant coronary artery disease (TCAD) is a major cause of mor-
tality in patients after orthotopic heart transplantation (OHT). Use of systemic ever-
olimus has been shown to help prevent allograft vasculopathy in OHT patients. This
study examined the clinical and angiographic efﬁcacy, safety, and clinical outcomes of
Xience V, a second-generation everolimus-eluting stent (EES), in patients with
TCAD.
Methods: Post-OHT patients with hemodynamically signiﬁcant CAD (left main
50% or angiographic diameter stenosis 70%) underwent percutaneous coronary
intervention (PCI) with EES. We examined procedural success rates, one- and two-
year mortality, and myocardial infarction rates. Primary end-point was target lesion
revascularization (TLR). Surveillance angiography was performed at 1 year and
subsequently as clinically indicated on a per-patient basis. Quantitative coronary
angiography (QCA) was used for stenosis analysis at baseline, post-procedure, and
follow-up.
Results: 23 patients were included in the study. PCI was performed in 43 lesions
with 45 denovo EES placed. 2 stents were placed into the left main, 20 in the left
anterior descending, 12 in the right coronary, and 9 in the left circumﬂex artery. The
average stent length was 17.16.2mm and the average stent diameter was
2.90.6mm. Procedural success rate was 100%. All patients received angiographic
follow-up, with average length of follow-up 709348 days. There were no peri-
procedural, 1-year, or 2-year deaths/ MIs. Binary restenosis events were 5.57%
(3/45). Target vessel revascularization (TVR) rate was 16.7% (5/30), and TLR rate
was 6.98% (3/43).B30 JACC Vol 64/11/Suppl B j SeptembConclusions: Long term follow-up of EES placements in OHT patients with TCAD
are associated with a very low incidence of target lesion revascularization. Continued
follow-up and further studies are indicated to determine whether EES can positively
affect the progression and overall outcome of TCAD.
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Background: Routine control angiography is a valuable tool with high-sensitivity in
detecting restenosis after coronary stenting. However, the prognostic role of restenosis
is still controversial. We investigated the impact of restenosis on 4-year mortality in
patients undergoing routine control angiography after coronary stenting.
Methods: All patients undergoing successful implantation of coronary stents for de
novo lesions from 1998 to 2009 and routine control angiography after 6 to 8 months at
2 centres in Munich, Germany were studied. Restenosis was deﬁned as diameter
stenosis50% in the in-segment area at follow-up angiography. The primary outcome
was 4-year mortality.
Results: This study included 10,004 patients with 15,004 treated lesions. Restenosis
was detected in 2,643 (26.4%) patients. Overall, there were 702 deaths during
follow-up. Of these, 218 deaths occurred among patients with restenosis and 484
deaths occurred among patients without restenosis (unadjusted hazard ratio - HR
1.19; [95% conﬁdence interval - CI 1.02 to 1.40]; p¼ 0.03). The Cox proportional
hazards model adjusting for other variables identiﬁed restenosis as an independent
correlate of 4-year mortality (HR 1.23; [95% CI 1.03 to 1.46]; p¼ 0.02). Other
independent correlates of 4-year mortality were age (for each 10-year increase, HR
2.34; [95% CI 2.12 to 2.60]; p< 0.001), diabetes mellitus (HR 1.68; [95% CI 1.41 to
1.99]; p< 0.001), current smoking habit (HR 1.39; [95% CI 1.09 to 1.76]; p¼ 0.01)
and left ventricular ejection fraction (for each 5% decrease, HR 1.39; [95% CI 1.31
to 1.48]; p< 0.001).
Conclusions: In this large cohort of patients with routine control angiography after
coronary stenting the presence of restenosis was a strong independent predictor of
4-year mortality.
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Background: Chest pain and angina have negative impact on patient quality of life
and medical costs. Real-world data describing the incidence of recurrent angina, chest
pain and their impact on re-intervention following percutaneous coronary intervention
(PCI) are scarce. We sought to describe the incidence and impact of post-PCI angina
and chest pain using real-world data from a large claims database.er 13–17, 2014 j TCT Abstracts/Angioplasty Overview and Outcomes
